Acute spinal cord injury changes the disposition of some, but not all drugs given intravenously

Spinal Cord

Volumn 45, Issue 9, 2007, Pages 603-608

  Garcia Lopez P ^a   Martinez Cruz A ^b   Guizar Sahagun G ^b   Castaeda Hernandez G ^c  

^a INSTITUTO NACIONAL DE CANCEROLOGÍA   (Mexico)

^b INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^c DEPARTAMENTO DE FÍSICA   (Mexico)

Author keywords

Bioavailability; Distribution; Excretion; Metabolism; Micro vascular blood flow; Pharmacokinetics

Indexed keywords

GENTAMICIN; NAPROXEN; PHENACETIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG DISPOSITION; DRUG DISTRIBUTION; DRUG EXCRETION; DRUG METABOLISM; FEMALE; KIDNEY FUNCTION TEST; LIVER BLOOD FLOW; LIVER FUNCTION TEST; MEXICO; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; SPINAL CORD INJURY;

ACUTE DISEASE; ANALGESICS, NON-NARCOTIC; ANIMALS; ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; FEMALE; GENTAMICINS; METABOLIC CLEARANCE RATE; NAPROXEN; PHENACETIN; RATS; RATS, SPRAGUE-DAWLEY; SPINAL CORD INJURIES; THORACIC VERTEBRAE;

EID: 34548508661     PISSN: 13624393     EISSN: 14765624     Source Type: Journal    
DOI: 10.1038/sj.sc.3102001     Document Type: Article

References (25)

1. Segal JL, Brunnemann SR. Clinical pharmacokinetics in patients with spinal cord injury. Clin Pharmacokinet 1989; 17: 109-129.
2. Sankaranarayanan A, Hemal AK, Pathak CM, Vaidyanathan S. Serum gentamicin levels in traumatic paraplegics following intramuscular administration in non-paralyzed limbs. Int J Clin Pharmacol Ther Toxicol 1989; 27: 540-543.
3. García-López P, Salas R. Bioavailability of diclofenac after intramuscular administration to rats with experimental spinal cord injury. J Pharmacol Toxicol Methods 1999; 42: 99-101.
4. 4Lavezo LA, Davis RL. Vancomycin pharmacokinetics in spinal cord injured patients: a comparison with age-matched, able-bodied controls. J Spinal Cord Med 1995; 18: 233-235.
5. Segal JL, Brunnemann SR, Eltorai IM, Vulpe M. Decreased systemic clearance of lorazepam in humans with spinal cord injury. J Clin Pharmacol 1991; 37: 651-666.
6. Guízar-Sahagún G, Grijalva I, Franco-Bourland R, Salgado-Ceballos H, Ibarra A. Neuroprotection of completely lancerated spinal cord of adult rats by homotropic and heterotropic transplantation. Restor Neurol Neurosci 1994; 61: 61-70.
7. García-López P, Pérez-Urizar J, Guízar- Sahagún G, Flores-Murrieta FJ, Grijalva I, Castañeda-Hernandez G. An experimental model for the study of pharmacokinetics alterations induced by spinal cord injury in the rat. Pharm Sci 1995; 1: 133-135.
8. García-López P, Pérez-Urizar J, Madrazo I, Guízar-Sahagún G, Castañeda-Hernández G. Oral paracetamol bioavailability in rats subjeted to experimental spinal cord injury. Biopharm Drug Dispos 1997; 18: 203-211.
9. Fuentes-Lara G, Guizar-Sahagun G, García-López P. Effect of experimental spinal cord injury on salicylate bioavailability after oral aspirin administration. J Pharmacol Toxicol Methods 1999; 42: 93-97.
10. Ibarra A et al. Alterations of cyclosporin-A pharmacokinetics after experimental spinal cord injury. J Neurotrauma 1996; 13: 267-272.
11. Segal JL, Brunnemann SR, Gray DR. Gentamicin bioavailability and single dose pharmacokinetics in spinal cord injury. Drug Intell Clin Pharm 1988; 22: 461-465.
12. Gilman TM, Brunnemman SR, Segal JL. Comparison of population pharmacokinetic models for gentamicin in spinal cord injury and able-bodied patients. Antimicrob Agents Chemother 1993; 37: 93-99.
13. Cruz-Antonio L, Flores-Murrieta FJ, García-López P, Guízar-Sahagún G, Castañeda-Hernández G. Understanding drug disposition alterations induced by acute spinal cord injury: role of injury level and route of administration for agents submitted to extensive liver metabolism. J Neurotrauma 2006; 23: 75-85.
14. Torres-Lopez JE, Robles MB, Perez-Urizar J, Flores-Murrieta FJ, Granados-Soto V. Determination of diclofenac in micro-whole blood samples by high-performance liquid chromatography with electrochemical detection. Application in a pharmacokinetic study. Arzneimittelforschung 1997; 47: 1040-1043.
15. Guízar-Sahagún G et al. Systemic microcirculation after complete high and low thoracic spinal cord section in rats. J Neurotrauma 2004; 21: 1614-1623.
16. Shargel L, Wu-Pong S, Yu A. Intravenous infusion. Applied Biopharmaceutics and Pharmacokinetics. McGraw-Hill: Singapore 2005, pp 107-130.
17. Rowland M, Tozer TN. Physiology concepts and kinetics. Clinical Pharmacokinetics Concepts and Applications. Lea and Febiger: USA 1989, pp 103-177.
18. Woerlee GM. Cardiac output. Kinetics and Dynamics of intravenous anesthetics. Kluwer Academic Publisher: London 1992 pp 188-226.
19. Tietze KJ, Putcha L. Factors affecting drug bioavailability in space. J Clin Pharmacol 1994; 34: 671-676.
20. Seifert J, Lob G, Probst J, Brendel W. Microcirculation and blood volume in rats before and after spinal cord injury. Paraplegia 1979; 17: 436-441.
21. Bach P, Rita P, Illis LS. Spinal shock: possible of receptor plasticity and non synaptic. Paraplegia 1993; 31: 82-87.
22. Atkinson PP, Atkinson JL. Spinal Shock. Mayo Clin Proc 1996; 71: 384-387.
23. Riff LJ, Jackson GG. Pharmacology of gentamicin in man. J Infect Dis 1971; 124: S98-S105.
24. 24Waldman J, Eisenberg B, Murata HG, Anderson X. Comparison of nomogram- and ultrasound-determined renal depths for calculation of glomerular filtration rates in spinal cord injury patients. Clin Nucl Med 1992; 17: 958-960.
25. Jacobson AF, Britell C, Little JW. Relation of changes in radionuclide measures of effective renal plasma flow and glomerular filtration rate in spinal cord injury patients. J Am Paraplegia Soc 1994; 17: 15-19.